
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Share this page To
In the lab, fujimycin slowed Alzheimer’s. (Fujimycin is an organ-transplant drug also called FK506 or Tacrolimus.) In past studies, similar drugs, like rapamycin and ciclosporin,
Newer blood tests accurately predict Alzheimer’s. This opens the door to earlier detection and treatment. Be cautious: only taking these tests with guidance from a medical expert.
MEDICATION VIDEO + ARTICLE: From allergies to moods, most of us get relief from drugs known as “anticholinergics”. Some raise dementia risk, some don’t. Do we always need them? A study of 300,000 people offers answers to help you and your doctor better weigh the risks and benefits.
Ambien (Zolpidem), a sleeping pill, was studied to see its effects on the brain. Learn to think twice before reaching for a sleeping pill – while you can still think clearly.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Visit Alzheimer's Weekly On